The Immune System in Critical Illness

Clinics in Chest Medicine

Volumn 29, Issue 4, 2008, Pages 605-616

  Marshall, John C ^a,b   Charbonney, Emmanuel ^a,b   Gonzalez, Patricia Duque ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Bacteria; Coagulation; Innate immunity; Lymphocytes; Macrophages; Neutrophils; Sepsis; Toll like receptors

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; CRITICAL ILLNESS; DISEASE COURSE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; MUCOSAL IMMUNITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REVIEW; SEPSIS;

BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; BYSTANDER EFFECT; CRITICAL ILLNESS; CYTOKINES; EVOLUTION; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; IMMUNITY, INNATE; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 54049140427     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.08.001     Document Type: Review

References (83)

1. Matzinger P. The danger model: a renewed sense of self. Science 296 5566 (2002) 301-305
2. Lederberg J. Infectious history. Science 288 5464 (2000) 287-293
3. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu Rev Med 31 (1977) 107-133
4. Hudault S., Guignot J., and Servin A.L. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 49 1 (2001) 47-55
5. Charles P.E., Dalle F., Aube H., et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31 3 (2005) 393-400
6. Hooper L.V., and Gordon J.I. Commensal host-bacterial relationships in the gut. Science 292 5519 (2001) 1115-1118
7. Souza D.G., Viera A.T., Soares A.C., et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173 6 (2004) 4137-4146
8. O'Neill A.J., Doyle B.T., Molloy E., et al. Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proteins during spontaneous and delayed apoptosis. Shock 21 6 (2004) 512-518
9. Luk T., Malam Z., and Marshall J.C. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83 4 (2008) 804-816
10. Netea M.G., Van Der Graaf C.A., Vonk A.G., et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 185 10 (2002) 1483-1489
11. Marshall J.C. Lipopolysaccharide: an endotoxin or an exogenous hormone?. Clin Infect Dis 41 Suppl 7 (2005) S470-S480
12. Giannella R.A., Broitman S.A., and Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 13 (1972) 251-256
13. Begley M., Gahan G.C., and Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 29 4 (2005) 625-651
14. Young P.J., Pakeerathan S., Blunt M.C., et al. A low-volume, low-pressure tracheal tube cuff reduces pulmonary aspiration. Crit Care Med 34 3 (2006) 632-639
15. Sackner M.A., Hirsch J., and Epstein S. Effect of cuffed endotracheal tubes on tracheal mucous velocity. Chest 68 6 (1975) 774-777
16. Bassi G.L., Zanella A., Cressoni M., et al. Following tracheal intubation, mucus flow is reversed in the semirecumbent position: possible role in the pathogenesis of ventilator-associated pneumonia. Crit Care Med 36 2 (2008) 518-525
17. Adair C.G., Gorman S.P., Feron B.M., et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 25 10 (1999) 1072-1076
18. Pugin J., Dunn-Siegrist I., Dufour J., et al. Cyclic stretch of human lung cells induces an acidification and promotes bacterial growth. Am J Respir Cell Mol Biol 38 3 (2008) 362-370
19. Lin C.Y., Zhang H., Cheng K.C., et al. Mechanical ventilation may increase susceptibility to the development of bacteremia. Crit Care Med 31 5 (2003) 1429-1434
20. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34 2 (2006) 344-353
21. Marshall J.C. The gastrointestinal flora and its alterations in critical illness. Curr Opin Crit Care 5 (1999) 119-125
22. Van Der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 43 (1989) 69-87
23. Dann S.M., and Eckmann L. Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 23 2 (2007) 115-120
24. Lee J., Mo J.H., Katakura K., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8 12 (2006) 1327-1336
25. Rescigno M., Urbano M., Valzasina B., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 4 (2001) 361-367
26. McCracken V.J., and Lorenz R.G. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 3 1 (2001) 1-11
27. Johanson W.G., Pierce A.K., and Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med 281 (1969) 1137-1140
28. Du Moulin G.C., Hedley-Whyte J., Paterson D.G., et al. Aspiration of gastric bacteria in antacid treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1 (1982) 242-245
29. Marshall J.C., Christou N.V., and Meakins J.L. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 218 (1993) 111-119
30. Wells C.L., Maddaus M.A., and Simmons R.L. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10 (1988) 958-979
31. Nathens A.B., and Marshall J.C. Selective decontamination of the digestive tract in surgical patients. Arch Surg 134 (1999) 170-176
32. Patel N.J., Zaborina O., Wu L., et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol 292 1 (2007) G134-G142
33. Wu L., Estrada O., Zaborina O., et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science 309 5735 (2005) 774-777
34. Khor C.C., Chapman S.J., Vannberg F.O., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39 4 (2007) 523-528
35. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 4 (2006) 783-801
36. Mold C., Nakayama S., Holzer T.J., et al. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med 154 (1981) 1703-1708
37. Fujita T., Matsushita M., and Endo Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol Rev 198 (2004) 185-202
38. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 8 (2001) 675-680
39. Anderson K.V., Jürgens G., and Nüsslein-Vollhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42 3 (1985) 779-789
40. Walport M.J. Complement. N Engl J Med 344 14 (2001) 1058-1066
41. Calvano S.E., Xiao W., Richards D.R., et al. A network-based analysis of systemic inflammation in humans. Nature 437 7061 (2005) 1032-1037
42. Lee J.H., Del Sorbo L., Khine A.A., et al. Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo. Am J Respir Crit Care Med 168 12 (2003) 1462-1470
43. Lorente J.A., and Marshall J.C. Neutralization of tumor necrosis factor (TNF) in pre-clinical models of sepsis. Shock 24 Suppl 1 (2005) 107-119
44. Dinarello C.A. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10 4 (2004) 201-222
45. Suffredini A.F., Fantuzzi G., Badolato R., et al. New insights into the biology of the acute phase response. J Clin Immunol 19 4 (1999) 203-214
46. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
47. Marshall J.C. Neutrophils in the pathogenesis of sepsis. Crit Care Med 33 Suppl 12 (2005) S502-S505
48. Faurschou M., and Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5 (2003) 1317-1327
49. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 64 1 (1998) 14-18
50. Tuin A., Huizinga-Van der Vlag A., van Loenen-Weemaes A.M., et al. On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 290 2 (2006) G377-G385
51. Watson R.W.G., Redmond H.P., Wang J.H., et al. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 156 (1996) 3986-3992
52. Brinkmann V., and Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 5 8 (2007) 577-582
53. Clark S.R., Ma A.C., Taverner S.A., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13 4 (2007) 463-469
54. Smith J.A. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 56 (1994) 672-686
55. Marshall J.C. Inflammation, coagulopathy, and the pathogenesis of the multiple organ dysfunction syndrome. Crit Care Med 29 Suppl (2001) S99-S106
56. Könlein T., and Welte T. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment. Am J Med 121 1 (2008) 3-9
57. Meneghin A., and Hogaboam C.M. Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117 3 (2007) 530-538
58. Savill J.S., Wyllie A.H., Henson J.E., et al. Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 83 (1989) 865-875
59. Marshall J.C., Malam Z., and Jia S.H. Modulating neutrophil apoptosis. Sepsis: new insights, new therapies (2007), John Wiley & Sons, Chichester (UK) p. 53-72
60. Sookhai S., Wang J.J., McCourt M., et al. A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 235 2 (2002) 285-291
61. Beutler B. Innate immunity: an overview. Mol Immunol 40 12 (2004) 845-859
62. Steinman R.M., and Banchereau J. Taking dendritic cells into medicine. Nature 449 7161 (2007) 419-426
63. Trombetta E.S., and Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23 (2005) 975-1028
64. Korn T., Oukka M., Kuchroo V., et al. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19 6 (2007) 362-371
65. Delves P.J., and Roitt I.M. The immune system. First of two parts. N Engl J Med 343 1 (2000) 37-49
66. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24 7 (1996) 1125-1128
67. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 2 (2003) 238-250
68. Casey L.C., Balk R.A., and Bone R.C. Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119 (1993) 771-778
69. Taniguchi T., Koido Y., Aiboshi J., et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27 7 (1999) 1262-1264
70. Marie C., Muret J., Fitting C., et al. Interleukin-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome. Crit Care Med 28 7 (2000) 2277-2282
71. Jimenez M.F., Watson R.W.G., Parodo J., et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome (SIRS). Arch Surg 132 (1997) 1263-1270
72. Taneja R., Parodo J., Kapus A., et al. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential (ΔΨM) and reduced caspase-9 activity. Crit Care Med 32 7 (2004) 1460-1469
73. Romaschin A.D., Foster D.M., Walker P.M., et al. Let the cells speak: neutrophils as biologic markers of the inflammatory response. Sepsis 2 2 (1998) 119-125
74. Arraes S.M., Freitas M.S., da Silva S.V., et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 108 9 (2006) 2906-2913
75. Docke W.D., Randow F., Syrbe U., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Med 3 6 (1997) 678-681
76. Guisset O., Dilhuydy M.S., Thiébaut R., et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med 33 1 (2007) 148-152
77. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168 5 (2002) 2493-2500
78. Hotchkiss R.S., Swanson P.E., Freeman B.D., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27 7 (1999) 1230-1251
79. Christou N.V., Meakins J.L., Gordon J., et al. The delayed hypersensitivity response and host resistance in surgical patients. Ann Surg 222 (1995) 534-548
80. Keane R.M., Birmingham W., Shatney C.M., et al. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 156 (1983) 163-167
81. Nohr C.W., Christou N.V., Broadhead M., et al. Failure of humoral immunity in surgical patients. Surg Forum 34 (1983) 127-129
82. Nohr C.W., Latter D.A., Meakins J.L., et al. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide. Surgery 100 (1986) 229-238
83. Marshall J.C. Sepsis: rethinking the approach to clinical research. J Leukoc Biol 83 3 (2008) 471-482